Prestige Consumer Healthcare (PBH) EPS (Basic) (2010 - 2025)

Prestige Consumer Healthcare's EPS (Basic) history runs 16 years deep, the most recent figure standing at $0.98 for Q4 2025.

• On a quarterly basis, EPS (Basic) fell 20.75% year-over-year to $0.98 in Q4 2025; TTM through Dec 2025 was $3.9, a 9.7% decrease from a year earlier, with the FY2025 full-year figure at $4.32, up 2.64% from the prior year.
• EPS (Basic) grew to $0.98 in Q4 2025 per PBH's latest filing, from $0.86 in the prior quarter.
• Across five years, EPS (Basic) topped out at $1.23 in Q4 2024 and bottomed at -$4.82 in Q1 2023.
• The 5-year median for EPS (Basic) is $1.02 (2022), against an average of $0.72.
• Across the five-year window, EPS (Basic) tumbled 565.26% in 2023 and soared 120.61% in 2024, its largest moves.
• Year by year, EPS (Basic) stood at $1.0 in 2021, then increased by 4.73% to $1.05 in 2022, then climbed by 2.01% to $1.07 in 2023, then gained by 15.39% to $1.23 in 2024, then retreated by 20.75% to $0.98 in 2025.
• Per Business Quant, the three latest PBH EPS (Basic) figures stand at $0.98 (Q4 2025), $0.86 (Q3 2025), and $0.96 (Q2 2025).